Latest filing published 30 Dec 2009 for NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, €469.
Insider track record
No signal scores available.
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.8%Entry 0.76 · Close at T+365 0.90
- -77.0%Entry 2.95 · Close at T+365 0.68
- -73.1%Entry 2.60 · Close at T+365 0.70
- -30.0%Entry 27.09 · Close at T+365 18.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John B. Stuppin: trading record in brief
John B. Stuppin has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Neurobiological Technologies Inc /CA/ and Energy Focus, Inc/de. Over a trading history stretching from 3 March 2006 to 29 December 2009, the count stands at 12 filings.
Both buying and selling appear: 9 purchases worth €158k, against 1 sale worth €469. Taken together, the purchases exceed the sales by €157k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises. 2009 to date brings no purchases and 1 sale.
In size, the median ticket on the buying side is €15k. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -15.3%. This is a record of the past, not a forecast.
The record was last updated on 30 December 2009 with an open-market sale (€469) in Neurobiological Technologies Inc /CA/. The most recent open-market purchase was published on 16 October 2008, 6,598 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John B. Stuppin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,608 shares@ US$0.12Common StockSEC:0001181431-09-059127:0
- 15,000 shares@ US$0.65Common StockSEC:0001181431-09-049010:0
- 9,000 shares@ US$0.85Common StockSEC:0001181431-08-057520:0Canonical exit: 13 Jan 2009 (T+90)
- 1,000 shares@ US$0.8699Common StockSEC:0001181431-08-057520:1Canonical exit: 13 Jan 2009 (T+90)
- 7,500 shares@ US$3.08Common StockSEC:0001144204-08-016184:0Canonical exit: 12 Jun 2008 (T+90)
- 2,000 shares@ US$3.30Common StockSEC:0001181431-07-073503:0Canonical exit: 2 Mar 2008 (T+90)
- 200 shares@ US$3.31Common StockSEC:0001181431-07-073503:1Canonical exit: 2 Mar 2008 (T+90)
- 7,800 shares@ US$3.32Common StockSEC:0001181431-07-073503:2Canonical exit: 2 Mar 2008 (T+90)
- 7,000 shares@ US$3.26Common StockSEC:0001181431-07-073503:3Canonical exit: 2 Mar 2008 (T+90)
- 43,600 shares@ US$2.75Common StockSEC:0001181431-07-066948:0Canonical exit: 31 Jan 2008 (T+90)
- 8,060 shares@ US$4.30COMMON STOCKSEC:0001275287-07-001499:0
- 5,000 shares@ US$3.82Common StockSEC:0001181431-06-016281:0Canonical exit: 1 Jun 2006 (T+90)
12 of 12 declarations
